Clinical Trial Update: An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic Leukemia

View source ↗

Summary

This observational study evaluates adding MabThera (rituximab) therapy to initial treatment in patients with untreated chronic lymphocytic leukemia. The study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• MabThera (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chronic Lymphocytic Leukemia | Status: COMPLETED